1 / 4

Developing and Using a Referral Network

Learn effective methods for developing referral networks, negotiating change, and setting realistic goals for managing chronic diseases like alcohol abuse. Understand the importance of provider feedback and support in improving patient adherence and reducing relapse rates.

simpsonh
Download Presentation

Developing and Using a Referral Network

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Developing and Using a Referral Network • Methods for negotiating change • Provider expectations: setting realistic goals for change in a chronic disease • http://findtreatment.samhsa.gov

  2. For the non-dependent high risk drinker…. • You have the opportunity to address an acute problem and have a big effect on health outcomes • Sobell: Many high risk drinkers will cut back and quit on their own • Provider feedback can play an influential role

  3. For the dependent drinker….

  4. Alcohol abuse resembles other chronic illnesses… • <30% of patients with asthma, HTN, diabetes adhere to prescribed diet and/or behavioral changes and 50% experience yearly recurrence requiring medical care • 50-60% of patients discharged from substance abuse treatment are abstinent at 1 year • As in other chronic diseases, poor adherence and relapse is predicted by low SES, co-morbid psych conditions and lack of family and social supports • Substance abuse should be insured, monitored, treated and evaluated like other chronic diseases McClellan AT, Lewis DC, et al. JAMA 2000; 284:1689-1695.

More Related